Prestige Wealth Management Group »

Terns Pharmaceuticals shares owned by Prestige Wealth Management Group

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Prestige Wealth Management Group from 13F filings

Historical chart of Prestige Wealth Management Group investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Prestige Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Prestige Wealth Management Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.2k 500 8.34

More positions owned by Prestige Wealth Management Group

Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Broad Usd High (USHY)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Spdr Ser Tr Portfolio Crport (SPBO)
Apple (AAPL)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Wisdomtree Tr Us Quality Grow (QGRW)
Colgate-Palmolive Company (CL)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Select Sector Spdr Tr Technology (XLK)
Vanguard Index Fds Value Etf (VTV)
Spdr Ser Tr S&P 400 MDCP GRW (MDYG)

View all positions for Prestige Wealth Management Group

Top funds holding Terns Pharmaceuticals

OrbiMed Advisors
Deep Track Capital
Soleus Capital Management
BlackRock
BlackRock
Citadel Advisors
VR Adviser
Schonfeld Strategic Advisors
Point72 Asset Management
Vanguard Group
Avidity Partners Management
Driehaus Capital Management
ExodusPoint Capital Management
T. Rowe Price Associates
Geode Capital Management

View all funds holding Terns Pharmaceuticals